Departments of Pediatrics and
Departments of Pediatrics and.
Pediatrics. 2021 May;147(5). doi: 10.1542/peds.2020-037812. Epub 2021 Feb 23.
In children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, virological characteristics and correlation with disease severity have not been extensively studied. The primary objective in this study is to determine the correlation between SARS-CoV-2 viral load (VL) in infected children with age, disease severity, and underlying comorbidities.
Children <21 years, screened for SARS-CoV-2 at the time of hospitalization, who tested positive by polymerase chain reaction were included in this study. VL at different sites was determined and compared between groups.
Of the 102 children included in this study, 44% of the cohort had asymptomatic infection, and children with >1 comorbidity were the most at risk for severe disease. VL in children with symptomatic infection was significantly higher than in children with asymptomatic infection (3.0 × 10 vs 7.2 × 10 copies per mL; = .001). VL in the respiratory tract was significantly higher in children <1 year, compared with older children (3.3 × 10 vs 1.3 × 10 copies per mL respectively; < .0001), despite most infants presenting with milder illness. Besides the respiratory tract, SARS-CoV-2 RNA was also detectable in samples from the gastrointestinal tract (saliva and rectum) and blood. In 13 children for whom data on duration of polymerase chain reaction positivity was available, 12 of 13 tested positive 2 weeks after initial diagnosis, and 6 of 13 continued to test positive 4 weeks after initial diagnosis.
In hospitalized children with SARS-CoV-2, those with >1 comorbid condition experienced severe disease. SARS-CoV-2 VL in the respiratory tract is significantly higher in children with symptomatic disease and children <1 year of age.
在儿童严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染者中,病毒学特征及其与疾病严重程度的相关性尚未得到广泛研究。本研究的主要目的是确定感染儿童的 SARS-CoV-2 病毒载量(VL)与年龄、疾病严重程度和潜在合并症之间的相关性。
本研究纳入了在住院期间因 SARS-CoV-2 筛查而检测到聚合酶链反应阳性的<21 岁的儿童。比较了不同部位的 VL 并在组间进行了比较。
本研究纳入的 102 例儿童中,44%为无症状感染,合并>1 种合并症的儿童患严重疾病的风险最高。有症状感染儿童的 VL 明显高于无症状感染儿童(3.0×10 拷贝/ml 比 7.2×10 拷贝/ml;P=0.001)。<1 岁儿童的呼吸道 VL 明显高于年龄较大的儿童(3.3×10 拷贝/ml 比 1.3×10 拷贝/ml;P<0.0001),尽管大多数婴儿的疾病较轻。除了呼吸道外,SARS-CoV-2 RNA 还可在胃肠道(唾液和直肠)和血液样本中检测到。在 13 例可获得聚合酶链反应阳性持续时间数据的儿童中,12 例在初次诊断后 2 周内均为阳性,6 例在初次诊断后 4 周内持续阳性。
在住院的 SARS-CoV-2 感染儿童中,合并>1 种合并症的儿童病情严重。有症状疾病和<1 岁的儿童的呼吸道 SARS-CoV-2 VL 明显更高。